Drug Trial Radar · NCT06164730
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
85
Planned (sponsor's estimate)
Start
Apr 30, 2024
Primary completion
Oct 2026
Study completion Oct 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Dec 11, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Base-editing Technology Designed to Disrupt the Expression of the PCSK9 Gene in the Liver and Lower Circulating PCSK9 and LDL-C. This Study is Designed to Determine the Safety and Pharmacodynamic Profile of VERVE-102 in This Patient Population.
Conditions
- Heterozygous Familial Hypercholesterolemia
- Premature Coronary Heart Disease
Interventions
VERVE-102Drug
Intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs)Time frame: up to Day 365
Locations
27 sites in 6 countries. Site status is shown where the registry gives one.
Clinical Study Center
Dothan, Alabama · Recruiting
Clinical Study Center
Pomona, California · Recruiting
Clinical Study Center
Boca Raton, Florida · Recruiting
Clinical Study Center
Jacksonville, Florida · Recruiting
Clinical Study Center
Winter Park, Florida · Recruiting
Clinical Study Center
Indianapolis, Indiana · Recruiting
Clinical Study Center
High Point, North Carolina · Recruiting
Clinical Study Center
Philadelphia, Pennsylvania · Recruiting
Clinical Study Center
DeSoto, Texas · Recruiting
Clinical Study Center
Renton, Washington · Recruiting
Clinical Study Center
Adelaide, Australia · Recruiting
Clinical Study Center
Melbourne, Australia · Recruiting
Clinical Study Center
Sydney, Australia · Recruiting
Clinical Study Center
Chicoutimi, Canada · Recruiting
Clinical Study Center
Hamilton, Canada · Recruiting
Clinical Study Center
Montreal, Canada · Recruiting
Clinical Study Center
Québec, Canada · Recruiting
Clinical Study Center
Toronto, Canada · Recruiting
Clinical Study Center
Vancouver, Canada · Recruiting
Clinical Study Center
Rehovot, Israel · Recruiting
Clinical Study Center
Christchurch, New Zealand · Recruiting
Clinical Study Center
Birmingham, United Kingdom · Recruiting
Clinical Study Center
Cambridge, United Kingdom · Recruiting
Clinical Study Center
Edinburgh, United Kingdom · Recruiting
Clinical Study Center
London, United Kingdom · Recruiting
Clinical Study Center
Manchester, United Kingdom · Recruiting
Clinical Study Center
Nottingham, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.